3Dominguez M A, Petre M A, Neal M S, et al. Bisphenol A con-centration-dependently increases human granulosa-lutein cell ma-trix metalloproteinase-9 ( MMP-9) enzyme output [ J ]. Reproduc-tive Toxicology,2008,25 ( 4 ) ; 420-425.
5Homburg R, Lambalk C B. Polycystic ovary syndrome in adoles-cence-a therapeutic conundrum [ J ]. Human Reproduction,2004’ 19(5) : 1039-1042.
6Van Hooff M H A, Voorhorst F J, Kaptein M B H, et al. Predictivevalue of menstrual cycle pattern, body mass index, hormone levelsand polycystic ovaries at age 15 years for oligo - amenorrhoea at age18 years[J]. Human Reproduction, 2004, 19(2) : 383-392.
7McCartney C R,Prendergast K A,Chhabra S,et al. The associ-ation of obesity and hyperandrogenemia during the pubertal transi-tion in girls: obesity as a potential factor in the genesis of postpu-bertal hyperandrogenism [ J ]. Journal of Clinical Endocrinology &Metabolism, 2006’ 91(5) : 1714-1722.
8Kalra A, Nair S, Rai L. Association of obesity and insulin resistancewith dyslipidemia in Indian women with polycystic ovarian syndrome[J]. Indian Journal of Medical Sciences,2006,60( 11) :447.
9Wang J X,Davies M J, Norman R J. Polycystic ovarian syndromeand the risk of spontaneous abortion following assisted reproduc-tive technology treatment [ J ]. Human Reproduction,2001,16(12):2606-2609.
10Jakubowicz D J,Iuomo M J, Jakubowicz S,et al. Effects of met-formin on early pregnancy loss in the polycystic ovary syndrome[J]. Journal of Clinical Endocrinology & Metabolism, 2002, 87(2):524-529.
